Sign inCreate account

Report workspace tools

NCT02166437UNKNOWNanonymous

Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese, Prospective Study

Sponsor

Source record

Tomidahama Hospital

Phase

Source record

Observational

Modality

AI-normalized

monoclonal antibody

Target

AI-normalized

Osteoporosis

Indication / condition

AI-normalized

Osteoporosis

Intervention

Source record

Detailed source ingestion pending.

Source & freshness

Source record

NCT ID

NCT02166437

Original source

ClinicalTrials.gov

Source last updated

Oct 19, 2016

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT02166437

Title

Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese, Prospective Study

Sponsor

Tomidahama Hospital

Status

UNKNOWN

Phase

Observational

Condition raw

Osteoporosis

Condition normalized

Osteoporosis

Modality raw

Osteoporosis

Modality normalized

monoclonal antibody

Target raw

Osteoporosis

Target normalized

Osteoporosis

Interventions

Detailed source ingestion pending

Public preview

Source record

This clinical trial investigates the efficacy of bisphosphonate and denosumab therapies following teriparatide treatment in Japanese patients with severe osteoporosis. The study aims to analyze bone mineral density (BMD), bone turnover markers, and fracture prevention effects in a cohort of 500 patients.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese, Prospective Study

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT02166437

Status

UNKNOWN

Phase

Observational

Sponsor

Tomidahama Hospital

Executive brief

Investment-Ready Snapshot

This clinical trial investigates the efficacy of bisphosphonate and denosumab therapies following teriparatide treatment in Japanese patients with severe osteoporosis. The study aims to analyze bone mineral density (BMD), bone turnover markers, and fracture prevention effects in a cohort of 500 patients.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedOct 19, 2016
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT02166437

Indication

Osteoporosis

Modality

monoclonal antibody

Target

Osteoporosis

Intervention

Not reported

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.